Inside AAPS NBC with AAPS President Dr. Russ Weiner

About this episode

Dr. Russ Weiner discusses the state of rare disease research and the evolution of therapeutic modalities at the AAPS NBC conference.

In this special episode (#34) of BioTalk Unzipped , recorded live at the AAPS NBC conference in Boston, Gregory Austin and Dr. Chad Briscoe sit down with AAPS President Dr. Russ Weiner for an unfiltered look inside AAPS NBC, at the state of rare disease research, the evolution of therapeutic modalities, and the human stories that drive scientific innovation. From navigating the emotional weight of personal loss to watching his son experience the field firsthand, Russ shares not only his scientific insights but the heart behind his leadership. The conversation spans topics like the rising promise of AI diagnostics, challenges with biomarker sampling logistics, the role of CROs in rare disease trials, and the future of autologous vs. allogeneic therapies. Dr. Weiner also offers an inspiring vision of industry collaboration, sharing how organizations like AAPS are becoming conduits for progress across low- and middle-income countries, underrepresented diseases, and emerging biotechnologies. Whether you're in the lab, the boardroom, or on the frontlines of clinical trials, this episode will reignite your sense of purpose in this field. 00:00 Preview & Intro 01:22 What is…

People in this episode

Hosts: Gregory Austin, Dr. Chad Briscoe

Guest: Dr. Russ Weiner

Topics covered

• rare disease research
• therapeutic modalities
• AI diagnostics
• biomarker sampling logistics
• clinical trials
• industry collaboration

Keywords

• rare disease
• therapeutics
• AI diagnostics
• biomarkers
• clinical trials
• AAPS NBC
• industry collaboration

Mentioned in this episode

Organizations: AAPS NBC, AAPS, CROs

Places: Boston

More episodes of BioTalk Unzipped

• The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi · June 11, 2026 · 30 min
• Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker · April 25, 2026 · 51 min
• Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains · March 19, 2026 · 1h 0m
• The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney · February 16, 2026 · 53 min
• Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins · December 22, 2025 · 49 min
• Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva · October 23, 2025 · 31 min